Results 111 to 120 of about 4,011 (178)

Navigating the Complexity of PH-ILD: From Molecular Mechanisms to Integrated Clinical Evaluation. [PDF]

Int J Mol Sci
Vasarmidi E, Calaras D, Kourouni I, Perelas A, Antoniou KM.   +4 more
europepmc   +1 more source

Association of Pericardial Tamponade With Initiation of Sotatercept in a Patient With Eisenmenger Syndrome. [PDF]

Pulm Circ
Aldawsari KA, Simpkin CT, Frank BS, Ivy DD.   +3 more
europepmc   +1 more source

Early Palliative Care in Degos Disease: A Case for Proactive Support in Rare, Life-Limiting Illnesses. [PDF]

Cureus
Williams K, Ellis-Wittenhagen J, Murphy T.   +2 more
europepmc   +1 more source

Exploring the therapeutic landscape of pulmonary hypertension associated with interstitial lung disease, with a focus on idiopathic pulmonary fibrosis: a narrative review. [PDF]

Front Pharmacol
Reccardini N, Da Re B, Mondini L, Salton F, Confalonieri M, Confalonieri P, Hughes M, Monteleone G, Ruaro B.   +8 more
europepmc   +1 more source

Development of PEG-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension

Pulmonary arterial hypertension is a chronic and fatal cardiovascular disease that affects the small arteries of the lungs. Current treatments, including treprostinil, require repeated administration due to their very short duration of action in the body.
Leone, Giuditta
core  

Transitions From Parenteral Prostacyclin Analogues to Selexipag in Patients With Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Kuebel DJ, Collins AR, Jose A, Guido MR, Elwing JM.   +4 more
europepmc   +1 more source

Real-World Outcomes of Inhaled Treprostinil in Pulmonary Hypertension Related to Interstitial Lung Disease: A Multicenter, Retrospective Analysis. [PDF]

J Cardiovasc Dev Dis
Kyle AR, Jose A, Catherman K, Elwing J, Sulica R, Zavorsky GS, Sood N.   +6 more
europepmc   +1 more source

Early parenteral prostacyclin therapy enables near-normal haemodynamics and treatment de-escalation in patients with haemodynamically severe pulmonary arterial hypertension. [PDF]

Eur Respir J
Kuronuma K, Quadery SR, Suetomi T, Goten C, Shimokawahara H, Matsubara H.   +5 more
europepmc   +1 more source

Combined Heart-Lung Transplant for Pulmonary Artery Aneurysm Secondary to Pulmonary Arterial Hypertension. [PDF]

JACC Case Rep
Kerai AP, Killian AC, Hoopes CW, Orozco-Hernandez E.   +3 more
europepmc   +1 more source

Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension. [PDF]

ERJ Open Res
AlEissa E, Kolkman L, Kapasi A, Peng D, Provencher S, Brunner N, Swiston J.   +6 more
europepmc   +1 more source